Posts

Engineering chemotaxis with DREADDs

A cool application of DREADD technology is found in a nice paper from the Wendall Lim lab at UCSF. This elegantly demonstrates how synthetic biology tools may be used to modulate cell motility (in this case chemotaxis) in the periphery.  It is likely that this approach will prove useful for all types of motile cells.

DREADD-induced presynaptic silencing

This is something I've been hearing about for some time and is now on-line in Neuron   from Stachniac, Ghosh and Sternson wherein they nicely demonstrate that hM4Di induces presynaptic silencing (via an unknown but likely interesting mechanism). They also report an  hM4D-neurexin variant which targets to axons.  We also have such a beast which may have i mproved surface expression and transport which may be similarly useful and is now available to all who wish to use it.   I see the Sternson variant is now available via ADDGENE. This will be a highly useful reagent for spatio-temporal control of synaptic transmission. I note that Steve Mahler from Gary Aston-Jones' lab has also reported in Nature Neuroscience what appears to be a similar observation related to presynaptic dopamine release via local infusion of CNO.

A useful approach for activation of specific neuronal pathways using DREADDs and CAV-1 Cre

A nice proof-of-concept paper was just published in PLOS ONE Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo Here canine associated adenovirus (CAV) expressing Cre-recombinase was used to specifically express hM3Dq ( AAV-DIO-hSyn-hM3Dq-mCherry ) in VTA neurons projecting to the striatum.  This paper is nice as it describes the technology in some detail. I note a similar use of this approach was previously described by Carter et al (Nature, 2013) . My sense is that this technology will be broadly useful...

New DREADD constructs and controls available from ADDGENE

A large batch of new plasmids (25) are now available via ADDGENE

CNO via minipump

I've received several queries regarding the delivery of CNO via Alzet (or similar) minipumps. As far as I'm aware no data using this as a delivery platform for CNO has been published (nor has my lab attempted this as we typically simply put CNO in the drinking water ( http://chemogenetic.blogspot.com/2014/03/cno-in-drinking-water.html ) Nonetheless--it should work.  Anyone with success/failure feel free to add comments.

CNO in drinking water

We frequently get requests regarding protocols for putting CNO in the drinking water for long-term studies. Here is our protocol: 1. Dissolve the CNO in a small volume of DMSO 2. Diluted the dissolved CNO in drinking water (e.g., 5mg/200ml) 3. Give mice with CNO drinking water  and protect from light using foil-wrapped bottles 4. The mice will receive 5mg/kg/day CNO (assume that mice weight 30g and consume 6ml water per day) 5. Prepare fresh daily. 6. A small amount of saccharine in the drinking water will mask the slightly bitter taste of CNO

IRES constructs redux

I've received quite a few emails regarding my decision to no longer offer high titer viral stocks of the various IRES constructs via the UNC vector core.  And thought I'd clarify for those interested.... The constructs work beautifully in our hands (see for instance our recent paper where we used the  CAMKII-hM4Di-IRES-mCitrene vector ) and yield highly reproducible and high levels of transduction in mice.   I have received a small number of emails from users who have not been able to reproducibly achieve high levels of transduction when the DIO-hSyn-DREADD-IRES-mCitrene constructs are used in combination with a Cre-driver line (even though they function well in our hands). My sense is that there was some variability on the packaging on the part of the vector core and I directed them to take them off line. The plasmids are/will be available from ADDGENE. Bryan